BY UNIVERSITY OF SURREY: Mother Nature could have the answer to treating several causes of blindness, according to a ground-breaking study involving scientists from the University of Surrey and the Eugene and Marilyn Glick Eye Institute at Indiana University School of Medicine in the USA.
The scientists have found and tested compounds from a group of plants that could possibly be used to treat the causes of degenerative eye diseases such as proliferative diabetic retinopathy. (read more)
BY MARIS KREIZMAN: My parents and I used to high-five one another when we learned that the child of someone very rich had been found to have Type 1 diabetes. We weren’t being mean, just desperate. I was given my diabetes diagnosis in 1987, when I was 9, and the years immediately following were spent fantasizing about a cure. A cure would solve all my problems, the physical, mental and financial strains of having a chronic illness. A cure would require fund-raising for charities that would then be able to sponsor life-changing research. Put more simply, a cure would require money — lots of it.
So, like monsters, my family and I rooted for offspring of the wealthy to join the broken-pancreas club, so that diabetes would become their pet cause and their fancy friends would get involved. The Juvenile Diabetes Research Foundation’s charity auction would make a killing. (read more)
BY TIMOTHY M. DALL: The average annual cost of diabetes for the entire U.S. population rose 13% between 2012 and 2017, according to findings presented in Diabetes Care.
“While recommendations from [the U.S. Preventive Services Task Force] and many government policies are based on clinical rather than economic outcomes, the high prevalence and large economic burden of diabetes suggests that policies and programs to help prevent or treat diabetes have the potential for substantial economic benefits as well as the health and quality-of-life benefits for people with diabetes and their families,” Timothy M. Dall, executive director, IHS Markit in Washington, D.C., told Endocrine Today. “If the nation could reduce diabetes prevalence and burden through appropriate prevention and treatment activities, the savings could allow scarce health care resources to be directed to other areas of need.” (read more)
BY AURELIE BALLON: Individuals who skipped breakfast were more likely to develop type 2 diabetes, according to research published in the Journal of Nutrition.
“Some available evidence from observational studies suggest that breakfast skipping is associated with an increased risk of type 2 diabetes. Our aim was to summarize findings from these epidemiological studies and investigate the influence of overweight for this association,” Sabrina Schlesinger, MSc, PhD, from the Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Germany, from told Healio Primary Care Today. (read more)
BY JAIME ROSENBERG: Diabetes represents a common comorbidity among patients with chronic obstructive pulmonary disease (COPD) and is associated with an increased risk of death, according to new study findings, which also found that treatment with metformin can mitigate this risk.
While it is known that metformin provides significant benefit to patients with diabetes, there has been speculation that the medication can also benefit patients with both COPD and diabetes because it also possesses pleiotropic anti-inflammatory and antioxidant actions.